ID   Am1010
AC   CVCL_W188
DR   Wikidata; Q54749652
RX   PubMed=20418894;
RX   PubMed=26004767;
CC   Population: Chinese.
CC   Doubling time: 42.395 hours (PubMed=20418894).
CC   Karyotypic information: Tetraploid karyotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Upper arm, skeletal muscle; UBERON=UBERON_0004255.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
RX   PubMed=20418894; DOI=10.1038/aps.2010.41; PMCID=PMC4002755;
RA   Li H.-L., Xie S.-M., Zhang L., Cai C.-J., Wang W., Huang J.,
RA   Wang D.-Y., Wen D.-P., Deng Q.-H., Zhong N.-S., He J.-X.;
RT   "Establishment and characterization of a new drug surviving cell line
RT   Am1010, derived directly from muscle metastases of a human lung
RT   adenocarcinoma patient with multi-drug-resistance to cisplatin, taxol,
RT   and gefitinib.";
RL   Acta Pharmacol. Sin. 31:601-608(2010).
//
RX   PubMed=26004767; DOI=10.3892/mmr.2015.3837; PMCID=PMC4526089;
RA   Li H.-L., He J.-X., Zhong N.-S., Hoffman R.M.;
RT   "Drug exposure in a metastatic human lung adenocarcinoma cell line
RT   gives rise to cells with differing adhesion, proliferation, and gene
RT   expression: implications for cancer chemotherapy.";
RL   Mol. Med. Rep. 12:3236-3242(2015).
//